On September 3, Sanofi announced that its tirizumab injection was approved by the China National Drug Administration for use in children over 8 years of age and adults with type 1 diabetes stage 2 to slow progression to type 1 diabetes stage 3.

Zhitongcaijing · 09/03/2025 06:25
On September 3, Sanofi announced that its tirizumab injection was approved by the China National Drug Administration for use in children over 8 years of age and adults with type 1 diabetes stage 2 to slow progression to type 1 diabetes stage 3.